BridgeBio Pharma to Present Additional Analyses from the Phase 3 ATTRibute-CM Study of Acoramidis in Patients with Transthyretin Amyloid Cardiomyopathy (ATTR-CM) at the 2024 ISA Meeting marketscreener.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from marketscreener.com Daily Mail and Mail on Sunday newspapers.
The hospital is a joint venture between BJC HealthCare and Encompass Health.
BIRMINGHAM, Ala. and BALLWIN, Mo., May 21, 2024 /PRNewswire/ BJC HealthCare, one of the largest nonprofit health care.